These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8865321)

  • 1. Transport of drugs across the Xenopus pulmonary membrane and their absorption enhancement by various absorption enhancers.
    Okumura S; Fukuda Y; Takahashi K; Fujita T; Yamamoto A; Muranishi S
    Pharm Res; 1996 Aug; 13(8):1247-51. PubMed ID: 8865321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of various absorption promoters on pulmonary absorption of drugs with different molecular weights.
    Morita T; Yamamoto A; Hashida M; Sezaki H
    Biol Pharm Bull; 1993 Mar; 16(3):259-62. PubMed ID: 7689890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of various absorption enhancers on the intestinal absorption of water soluble drugs by in vitro Ussing chamber method: correlation with an in situ absorption experiment.
    Sugiyama T; Yamamoto A; Kawabe Y; Uchiyama T; Quan YS; Muranishi S
    Biol Pharm Bull; 1997 Jul; 20(7):812-4. PubMed ID: 9255426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular weight-dependent lymphatic transfer of fluorescein isothiocyanate-labeled dextrans after intrapulmonary administration and effects of various absorption enhancers on the lymphatic transfer of drugs in rats.
    Hanatani K; Takada K; Yoshida N; Nakasuji M; Morishita Y; Yasako K; Fujita T; Yamamoto A; Muranishi S
    J Drug Target; 1995; 3(4):263-71. PubMed ID: 8821000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of insulin permeability and effects of absorption enhancers on its permeability by an in vitro pulmonary epithelial system using Xenopus pulmonary membrane.
    Yamamoto A; Tanaka H; Okumura S; Shinsako K; Ito M; Yamashita M; Okada N; Fujita T; Muranishi S
    Biol Pharm Bull; 2001 Apr; 24(4):385-9. PubMed ID: 11305600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
    Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
    J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane.
    Uchiyama T; Yamamoto A; Hatano H; Fujita T; Muranishi S
    Biol Pharm Bull; 1996 Dec; 19(12):1618-21. PubMed ID: 8996651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of protease inhibitors on the absorption of phenol red and fluorescein isothiocyanate dextrans from the rat intestine.
    Gotoh S; Nakamura R; Nishiyama M; Quan YS; Fujita T; Yamamoto A; Muranishi S
    J Pharm Sci; 1996 Aug; 85(8):858-62. PubMed ID: 8863277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane.
    Yamamoto A; Uchiyama T; Nishikawa R; Fujita T; Muranishi S
    J Pharm Pharmacol; 1996 Dec; 48(12):1285-9. PubMed ID: 9004192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphatic transfer of macromolecules after intrapulmonary administration in the presence or absence of various absorption enhancers in rats.
    Muranishi S; Fujita T; Murakami M; Yamamoto A
    Pharmazie; 1996 May; 51(5):331-6. PubMed ID: 8710955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of enhancers to increase nasal absorption using Ussing chamber technique.
    Hosoya K; Kubo H; Natsume H; Sugibayashi K; Morimoto Y
    Biol Pharm Bull; 1994 Feb; 17(2):316-22. PubMed ID: 7515747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine.
    Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
    Int J Pharm; 2008 Apr; 354(1-2):126-34. PubMed ID: 18206325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption characteristics of model compounds with different molecular weights from the serosal caecal surface in rats.
    Nishida K; Nose S; Kuma A; Mukai T; Kawakami S; Nakashima M; Sasaki H; Sakaeda T; Nakamura J
    J Pharm Pharmacol; 2002 Jul; 54(7):1005-9. PubMed ID: 12162704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Absorption-Enhancement and the Mechanism of the PAMAM Dendrimer on Poorly Absorbable Drugs.
    Lu J; Li N; Gao Y; Li N; Guo Y; Liu H; Chen X; Zhu C; Dong Z; Yamamoto A
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30103462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement potential of sucrose laurate (L-1695) on intestinal absorption of water-soluble high molecular weight compounds.
    Onishi H; Imura Y; Uchida M; Machida Y
    Curr Drug Deliv; 2012 Sep; 9(5):487-94. PubMed ID: 22520068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of cationic compounds as an absorption enhancer for nasal drug delivery.
    Natsume H; Iwata S; Ohtake K; Miyamoto M; Yamaguchi M; Hosoya K; Kobayashi D; Sugibayashi K; Morimoto Y
    Int J Pharm; 1999 Aug; 185(1):1-12. PubMed ID: 10425360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sodium taurodihydrofusidate on nasal drug delivery: differences in its concentration and penetrant molecular weight.
    Hosoya K; Kubo H; Akutsu T; Natsume H; Sugibayashi K; Morimoto Y
    Arch Pharm Res; 1994 Apr; 17(2):57-9. PubMed ID: 10319131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of absorbability of poorly water-soluble drugs: validity of the use of additives.
    Watanabe E; Sudo R; Takahashi M; Hayashi M
    Biol Pharm Bull; 2000 Jul; 23(7):838-43. PubMed ID: 10919363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers.
    Quan YS; Hattori K; Lundborg E; Fujita T; Murakami M; Muranishi S; Yamamoto A
    Biol Pharm Bull; 1998 Jun; 21(6):615-20. PubMed ID: 9657048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of pulmonary absorption of poorly absorbable macromolecules by hydroxypropyl-β-cyclodextrin grafted polyethylenimine (HP-β-CD-PEI) in rats.
    Zhang H; Huang X; Sun Y; Lu G; Wang K; Wang Z; Xing J; Gao Y
    Int J Pharm; 2015 Jul; 489(1-2):294-303. PubMed ID: 25959121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.